Eli Lilly and Company (LLY) closed at $1,411.49 on November 3, 2026, a decline of 0.36% from the prior session. The modest pullback came after a period of significant upward momentum for the pharmaceutical giant.
Over the past seven days, shares have advanced 10.35%, reflecting sustained buying interest in the stock. The broader 30-day window tells an even stronger story, with LLY posting a gain of 23.38% over that stretch.
The company's market capitalization stands at $1,262.67 billion, cementing its position as one of the largest publicly traded companies by that measure. The single-session dip appears limited in scope relative to the gains accumulated over the recent longer-term periods.
Trading in LLY continues to draw attention given the scale of its recent appreciation. Tuesday's slight decline does little to offset the substantial ground the stock has covered over the prior month.
